Misako Matsumoto Selected Research

RNA Virus Infections

2/2014	MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
11/2011	The TLR3/TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection.
12/2010	The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection.
1/2010	IL-6 and IFN-alpha from dsRNA-stimulated dendritic cells control expansion of regulatory T cells.
11/2008	Pan-vertebrate toll-like receptors during evolution.
10/2007	Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Misako Matsumoto Research Topics

Disease

41	Neoplasms (Cancer) 01/2020 - 01/2002
34	Infections 01/2022 - 10/2002
17	Virus Diseases (Viral Diseases) 02/2015 - 02/2002
16	Inflammation (Inflammations) 01/2020 - 03/2007
10	Melanoma (Melanoma, Malignant) 01/2018 - 12/2006
6	Bites and Stings (Sting) 04/2018 - 01/2013
6	RNA Virus Infections 02/2014 - 10/2007
5	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020 - 04/2015
4	Hepatocellular Carcinoma (Hepatoma) 12/2007 - 01/2002
3	Human Influenza (Influenza) 12/2018 - 12/2017
3	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2011
3	Necrosis 01/2013 - 05/2011
2	Carcinogenesis 04/2013 - 10/2010
2	Experimental Melanoma 04/2011 - 10/2010
2	Vesicular Stomatitis 01/2009 - 12/2006
2	Bacterial Infections (Bacterial Infection) 03/2005 - 11/2004
1	Severe Acute Respiratory Syndrome 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2022
1	Blister (Bulla) 01/2020
1	Erythema 01/2020
1	Pruritus (Itching) 01/2020
1	Pain (Aches) 01/2020
1	Lewis Lung Carcinoma 04/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Polyps 10/2017
1	Septic Shock (Toxic Shock Syndrome) 01/2017
1	Colonic Neoplasms (Colon Cancer) 08/2015

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 07/2018 - 08/2002
19	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2004
17	Antiviral Agents (Antivirals)IBA 07/2018 - 02/2006
16	AntigensIBA 01/2020 - 11/2003
16	CytokinesIBA 01/2019 - 01/2004
15	LigandsIBA 01/2019 - 10/2007
15	Double-Stranded RNA (RNA, Double Stranded)IBA 04/2018 - 05/2002
14	Interferon Type IIBA 01/2018 - 12/2010
13	InterferonsIBA 04/2018 - 09/2011
12	Pattern Recognition ReceptorsIBA 01/2020 - 12/2006
12	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2018 - 11/2003
10	Poly I-CIBA 04/2018 - 12/2006
9	VaccinesIBA 01/2022 - 01/2011
9	Toll-Like Receptor 3IBA 01/2020 - 11/2003
7	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2014 - 12/2006
5	Vaccine AdjuvantsIBA 12/2018 - 12/2015
5	DNA (Deoxyribonucleic Acid)IBA 04/2018 - 01/2013
5	Messenger RNA (mRNA)IBA 01/2018 - 03/2007
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 01/2017
4	ChemokinesIBA 04/2018 - 08/2009
4	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2016 - 08/2002
3	Immunoglobulin A (IgA)IBA 12/2018 - 12/2017
3	OvalbuminIBA 07/2018 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2010
3	Transcription Factors (Transcription Factor)IBA 10/2017 - 12/2006
3	PAM2-CSK4IBA 01/2017 - 04/2011
3	CaspasesIBA 01/2017 - 08/2015
3	Interleukin-12 (IL 12)IBA 08/2016 - 12/2007
3	Nucleic AcidsIBA 11/2015 - 11/2014
3	Viral RNAIBA 01/2013 - 09/2008
3	Complement System Proteins (Complement)IBA 12/2012 - 02/2002
3	Cell Wall SkeletonIBA 07/2010 - 05/2005
2	Cancer VaccinesIBA 01/2019 - 02/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2018 - 09/2012
2	Hemagglutinins (Hemagglutinin)IBA 12/2017 - 12/2007
2	Toll-Like Receptor 2IBA 01/2017 - 12/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 08/2015
2	Viral DNAIBA 04/2015 - 01/2013
2	LipopeptidesIBA 02/2015 - 04/2011
2	Antigen-Antibody Complex (Immune Complex)IBA 08/2014 - 05/2011
2	Interferon-betaIBA 01/2012 - 01/2009
2	Monoclonal AntibodiesIBA 05/2011 - 04/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2011 - 06/2008
2	Interleukin-23 (Interleukin 23)IBA 01/2011 - 06/2008
2	Protein Isoforms (Isoforms)IBA 03/2007 - 01/2002
2	FlagellinIBA 03/2005 - 11/2004
2	NF-kappa B (NF-kB)IBA 03/2005 - 11/2004
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2005 - 11/2004
1	aluminum sulfate (alum)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Bee Venoms (Bee Venom)IBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 12/2017
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2017
1	Interleukin-12 Subunit p40IBA 10/2017
1	LipopolysaccharidesIBA 01/2017
1	Reactive Nitrogen SpeciesIBA 01/2017
1	Toll-Like Receptor 4IBA 01/2017
1	Caspase 8 (Caspase-8)IBA 01/2017
1	Genetic Markers (Genetic Marker)IBA 01/2016
1	Interleukin-12 Subunit p35IBA 01/2016
1	Interleukin-33IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	AntibodiesIBA 01/2016
1	nasIBA 11/2015
1	KetonesIBA 08/2015

Therapy/Procedure

26	Immunotherapy 01/2020 - 11/2003
11	Therapeutics 01/2019 - 12/2007
1	Radiotherapy 04/2018
1	Intranasal Administration 01/2018
1	Subcutaneous Injections 08/2016